|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61M 5/315 | |||
| A61K 9/00 | |||
| A61K 47/18 |
| (11) | Number of the document | 3354280 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18161288.8 |
| Date of filing the European patent application | 2011-10-05 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 390283 P | 2010-10-06 | US |
| (72) |
DIX, Daniel B., US
TANG, Xiaolin, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (54) | STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-4 RECEPTOR (IL-4R) ANTIBODIES |
| STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-4 RECEPTOR (IL-4R) ANTIBODIES |